scholarly journals Gut Microbiota-A positive contributor in the process of intermittent fasting-mediated obesity control

2021 ◽  
Author(s):  
Bohan Rong ◽  
Qiong Wu ◽  
Muhammad Saeed ◽  
Chao Sun
Keyword(s):  
Gut Microbiota ◽  
Intermittent Fasting ◽  
Obesity Control

scholarly journals The effect of calorie intake, fasting, and dietary composition on metabolic health and gut microbiota in mice

BMC Biology ◽  
2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Ziyi Zhang ◽  
Xiaoyu Chen ◽  
Yuh Jiun Loh ◽  
Xin Yang ◽  
Chenhong Zhang
Keyword(s):  
Gut Microbiota ◽  
High Fat Diet ◽  
Metabolic Health ◽  
Metabolic Phenotype ◽  
Intermittent Fasting ◽  
High Fat ◽  
Eating Pattern ◽  
Positive Effects ◽  
Normal Chow ◽  
Ad Libitum

Abstract Background Calorie restriction (CR) and intermittent fasting (IF) can promote metabolic health through a process that is partially mediated by gut microbiota modulation. To compare the effects of CR and IF with different dietary structures on metabolic health and the gut microbiota, we performed an experiment in which mice were subjected to a CR or IF regimen and an additional IF control (IFCtrl) group whose total energy intake was not different from that of the CR group was included. Each regimen was included for normal chow and high-fat diet. Results We showed that in normal-chow mice, the IFCtrl regimen had similar positive effects on glucose and lipid metabolism as the CR regimen, but the IF regimen showed almost no influence compared to the outcomes observed in the ad libitum group. IF also resulted in improvements, but the effects were less marked than those associate with CR and IFCtrl when the mice were fed a high-fat diet. Moreover, CR created a stable and unique gut microbial community, while the gut microbiota shaped by IF exhibited dynamic changes in fasting-refeeding cycles. At the end of each cycle, the gut microbiota of the IFCtrl mice was similar to that of the CR mice, and the gut microbiota of the IF mice was similar to that of the ad libitum group. When the abundance of Lactobacillus murinus OTU2 was high, the corresponding metabolic phenotype was improved regardless of eating pattern and dietary structure, which might be one of the key bacterial groups in the gut microbiota that is positively correlated with metabolic amelioration. Conclusion There are interactions among the amount of food intake, the diet structure, and the fasting time on metabolic health. The structure and composition of gut microbiota modified by dietary regimens might contribute to the beneficial effects on the host metabolism.

scholarly journals Intermittent Fasting Alleviates Diabetes-induced Cognitive Decline via Gut Microbiota-metabolites-brain Axis (OR32-04-19)

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Zhigang Liu ◽  
Tian Yuan ◽  
Xiaoshuang Dai ◽  
Lin Shi ◽  
Xuebo Liu
Keyword(s):  
Cognitive Function ◽  
Gut Microbiota ◽  
Cognitive Decline ◽  
Critical Role ◽  
Development Program ◽  
Plasma Metabolites ◽  
Intermittent Fasting ◽  
Metabolic Function ◽  
Behavioral Tests ◽  
Omics Analysis

Abstract Objectives Cognitive decline is one of severe type 2 diabetes complications. Intermittent fasting (IF) is a promising dietary intervention for T2D risk reduction, but its protective effect and mechanism on diabetic cognitive dysfunction remain elusive. Gut microbiota plays a vital role interphasing diet and host physiology and pathology and highly affected by the dietary composition and patterns. It has been reported that the microbiota homeostasis is essential for maintenance of gut health and for modulating cognitive function. We hypothesized that gut microbiota might play a pivotal role in mediating protective effects of IF on diabetes-induced cognitive decline. Methods After a 28-day IF regimen treatment, cognitive behavioral tests and brain insulin signaling were assessed on db/db mice. The microbiota-metabolites-brain axis alterations were detected by multiple-omics analysis (transciptomics, 16S rRNA sequencing and metabolomics). A intergrade multi-omics analysis was performed to analyze the correlation among gut microbiota, plasma metabolites, and hippocampal gene expression. Results Here we found that a 28-day Intermittent fasting (IF) regimen improved cognitive deficits in db/db mice via a microbiota-metabolites-brain axis assessed by behavioral tests and multiple-omics analysis: IF activated AMPK/PGC1α signaling, enhanced mitochondrial biogenesis in hippocampus and elevated genes enriched in hippocampal metabolic function. Moreover, IF re-structured gut microbiota and improved plasma microbial metabolites in relation to diabetes and cognitive function, e.g., serotonin, 3-Indolepropionic acid, and bile acids. Integration of multi-omics data demonstrated strong links between IF-related genes, gut microbiome and metabolites. Furthermore, removal of gut microbiota with antibiotics partly abolished the observed benefits of IF on cognition and hippocampal metabolic function. Conclusions Taken together, the present study suggests a critical role of gut microbiota in connecting peripheral metabolism with brain function, which could lead to novel interventions against metabolism-implicated neurodegenerative pathophysiologies. Funding Sources This work was financially supported by the National Key Research and Development Program of China, National Natural Science Foundation of China.

scholarly journals Intermittent Fasting Improves Lipid Metabolism Through Changes in Gut Microbiota in Diet-Induced Obese Mice

2020 ◽  
Vol 26 ◽  
Author(s):  
Ya Deng ◽  
Wanjun Liu ◽  
Jianqing Wang ◽  
Jun Yu ◽  
Li-qi Yang
Keyword(s):  
Lipid Metabolism ◽  
Gut Microbiota ◽  
Intermittent Fasting ◽  
Obese Mice

Abstract P241: Intermittent Fasting Lowers Blood Pressure In A Rat Model Of Hypertension By Modulating The Gut Microbiota

Hypertension ◽  
2020 ◽  
Vol 76 (Suppl_1) ◽  
Author(s):  
Huanan Shi ◽  
Taylor Abo-Hamzy ◽  
Robert M Bryan ◽  
David J Durgan
Keyword(s):  
Blood Pressure ◽  
Gut Microbiota ◽  
Intermittent Fasting ◽  
Microbial Metabolites ◽  
Targeted Metabolomics ◽  
Oral Gavage ◽  
Spontaneously Hypertensive ◽  
Germ Free ◽  
Wistar Kyoto ◽  
Principle Coordinate Analysis

Studies have demonstrated that disruption of the gut microbiota, termed gut dysbiosis, plays a causal role in the development of hypertension (HT) in animal models and patients. Recent studies revealed that intermittent fasting alters the gut microbiota and the production of microbial metabolites. Thus, we hypothesized that every-other-day-fasting (EODF) would prevent elevations of blood pressure (BP) in spontaneously hypertensive stroke prone rat (SHRSP) by maintaining a healthy gut microbiota. Five-week old SHRSP rats and normotensive Wistar Kyoto (WKY) rats were randomized to be fed ad lib or on EODF for 10 weeks. BP was measured weekly, and cecal content and plasma were collected at the end of the study. To examine the roles of gut microbiota and microbial metabolites in hypertension, we performed whole-genome shotgun sequencing on cecal samples and non-targeted metabolomics on cecal contents and plasma. To examine the direct effects of the EODF altered microbiota on BP regulation and eliminate the confounding variable of fasting, pooled cecal contents of SHRSP and WKY animals fed ad lib or EODF were given to germ free (GF) rats by oral gavage. We found that ten-weeks EODF was able to prevent elevations of systolic BP (SBP) in SHRSP compared to ad lib fed SHRSP (~220 vs. ~170mmHg; n=6-8, p<0.05), and that germ free rats transplanted with SHRSP ad lib microbiota had a significantly higher SBP as compared to those transplanted with SHRSP EODF microbiota (~152 vs. ~140 mmHg; n=6-7, p<0.01), indicating that microbiota and their metabolites are accountable for the effects of EODF. Principle coordinate analysis showed that EODF significantly altered the overall composition of both WKY and SHRSP microbiota (WKY p<0.01, SHRSP p<0.009). Multi-omics analysis indicates distinct microbiome and metabolome in SHRSP compared to WKY, and significant alterations to each induced by EODF. These findings suggest that EODF is able to prevent hypertension in SHRSP, and this involves altering the gut microbiota and metabolome.

scholarly journals Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota

2017 ◽  
Vol 26 (4) ◽  
pp. 672-685.e4 ◽  
Author(s):  
Guolin Li ◽  
Cen Xie ◽  
Siyu Lu ◽  
Robert G. Nichols ◽  
Yuan Tian ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Intermittent Fasting

scholarly journals Is It Time to Use Probiotics to Prevent or Treat Obesity?

Nutrients ◽  
2018 ◽  
Vol 10 (11) ◽  
pp. 1613 ◽  
Author(s):  
Andrea Brusaferro ◽  
Rita Cozzali ◽  
Ciriana Orabona ◽  
Anna Biscarini ◽  
Edoardo Farinelli ◽  
...  
Keyword(s):  
Body Weight ◽  
Gut Microbiota ◽  
Overweight And Obesity ◽  
Microbiota Composition ◽  
Long Term Effects ◽  
Obesity Control ◽  
Treatment Of Obesity ◽  
Faecal Bacteria ◽  
Gut Microbiota Composition

In recent years, attention has been given to the role potentially played by gut microbiota in the development of obesity. Several studies have shown that in individuals with obesity, the gut microbiota composition can be significantly different from that of lean individuals, that faecal bacteria can exert a fundamental role in modulating energy metabolism, and that modifications of gut microbiota composition can be associated with increases or reductions of body weight and body mass index. Based on this evidence, manipulation of the gut microbiota with probiotics has been considered a possible method to prevent and treat obesity. However, despite a great amount of data, the use of probiotics to prevent and treat obesity and related problems remains debated. Studies have found that the probiotic effect on body weight and metabolism is strain specific and that only some of the species included in the Lactobacillus and Bifidobacterium genera are effective, whereas the use of other strains can be deleterious. However, the dosage, duration of administration, and long-term effects of probiotics administration to prevent overweight and obesity are not known. Further studies are needed before probiotics can be rationally prescribed for the prevention or treatment of obesity. Control of the diet and environmental and life-style factors that favour obesity development remain the best solution to problems related to weight gain.

scholarly journals Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairment

2020 ◽  
Vol 11 (1) ◽  
Author(s):  
Zhigang Liu ◽  
Xiaoshuang Dai ◽  
Hongbo Zhang ◽  
Renjie Shi ◽  
Yan Hui ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Gut Microbiota ◽  
Intermittent Fasting

scholarly journals Intermittent fasting - a potential approach to modulate the gut microbiota in humans? A systematic review

2021 ◽  
pp. 1-8
Author(s):  
Kate Llewellyn-Waters ◽  
Mohammad M. Abdullah
Keyword(s):  
Systematic Review ◽  
Clinical Trials ◽  
Gut Microbiota ◽  
Dietary Habits ◽  
Intermittent Fasting ◽  
Gut Health ◽  
Medline Search ◽  
Beneficial Effects ◽  
The Rich ◽  
The Impact

Research on gut microbiota has increased in popularity over the past decade, with evidence associating different dietary habits with changes in the makeup of the rich ecosystem of microorganisms that performs a variety of functions and induces a range of health effects, within and well beyond the gastrointestinal tract. Similarly, intermittent fasting (IF), an umbrella term describing various regimens of periods of voluntary abstinence from food and drink, has classically been associated with favourable impacts on cardiovascular risk factors, body weight, circadian biology, and, more recently, the gut health..The objective of this PRISMA systematic review was to summarize the peer-reviewed literature of clinical trials related to the impact of IF regimens on the gut microbiota. A MEDLINE search was conducted using PubMed and the keywords “intermittent fasting”, “gut microbiota”, “microbes”, and others. Whilst the field is still in its infancy, an emerging body of evidence suggests beneficial effects of IF on the health of the gut through increasing the microbial diversity and abundance, with possible clinical implications related to improving the immune function and ameliorating the metabolic status. Further research in larger clinical trials is warranted before practical recommendations for the public health can be made.

Sign in / Sign up

Export Citation Format

Share Document